The only patient with diabetes requiring insulin at baseline who was not admitted for a diabetes-related complication and did not require enteral feeding was able to continue their anti-diabetic regimen throughout CCRT (which included use of an OHG). The gene discussed is INS; the disease is diabetes mellitus.